Filter Results :

Your search for Biosimilars returned 40 reports

Sort by


The Future of the U.S. Biologics and Biosimilars Treatment Market for Psoriasis

13 Oct 2017  |  Published by:  MP Advisors
The new report from MP Advisors titled “The Future of the U.S. Biologics and Biosimilars Treatment Market for Psoriasis” examines in detail the current treatment landscape and the outlook through 2021 of psoriasis treatment market facing the U.S. Biologics and the Biosimilars. The report offers stro...

$ 4,000.00

Read More

Global Biologics and Biosimilars Market Research Report 2017

07 Sep 2017  |  Published by:  QYResearch
In this report, the global Biologics and Biosimilars market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.Geographically, this report is segmented into several key Regions, with production, consumption, ...

$ 2,900.00

Read More

The Future of Biosimilars in the USA: Mapping critical uncertainties and the impact of future events

01 Sep 2017  |  Published by:  FirstWord
The Future of Biosimilars in the USACan pharma resolve the litigation frenzy hampering biosimilars' market entry in the US? Is too much focus on legal wrangling stifling healthy competition and innovation? And, as the arguments rage, is the patient being forgotten? This report looks at recent progre...

$ 2,245.00

Read More

Global Biosimilars Market: - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

01 Sep 2017  |  Published by:  Precision Business Insights
Global Biosimilars Market: By Products Type (Monoclonal Antibodies, Recombinant Hormones, Recombinant Growth Factors, Immunomodulators, Anti-Inflammatory Agents, and Others), By Application (Oncology, Blood Disorders, Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases, Diabetes, and...

$ 4,400.00

Read More

2017-2022 Global and Regional Biologics and Biosimilars Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report

30 Aug 2017  |  Published by:  HNY Research
This report focus on global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applications from global and major regions such as Europe, North America, China, Japan, Southeast Asia and e...

$ 3,500.00

Read More

Japan Biosimilars - A start of Authorized Biosimilar Era? Biosimilar/BioPharma CMO opportunities - JP Conglomerates – A definite role to play for Global Market! Major JP Innovator vs. Early entrant Mid size Japanese companies- TA focus approach - A Win Win Game!

14 Aug 2017  |  Published by:  MP Advisors
In 2016, encouraging uptake of Lantus BS in Japan confirms strong foothold of the marketer, product mix targeted to DPC hospitals (Diagnostic Procedure Combination hospitals- ~4000) and early entry of the player are critical factors to decide biosimilar penetration and market share dynamics of Japan...

$ 4,000.00

Read More

2017 Global and Regional Biologics and Biosimilars Market Research Report Forecasts 2022

26 Jul 2017  |  Published by:  Tuoda Research
This report focus on Global and regional market providing information on major players like manufacturers suppliers distributors traders customers investors and etc. major types major applications from Global and major regions such as Europe North American South American Asia (Excluding China) China...

$ 2,800.00

Read More

2017 Global and Regional Biosimilars and Biologics Market Research Report Forecasts 2022

08 Jul 2017  |  Published by:  Tuoda Research
This report focus on Global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applications from Global and major regions such as Europe, North American, South American, Asia (Excluding C...

$ 2,800.00

Read More

Biosimilars Real World Evidence: Proving the point

01 Jul 2017  |  Published by:  FirstWord
Biosimilars Real World Evidence: Proving the pointBiosimilar manufacturers face an uphill struggle to fully mobilise their product portfolio. Against a background of aggressive defence strategies by originator companies, often sceptical prescribers must be brought on board, the anxieties of patients...

$ 2,245.00

Read More

Global Biosimilars Market Analysis 2011-2017 and Forecast 2018-2023

01 Jul 2017  |  Published by:  99Strategy
SnapshotA biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company.The global Biosimilars market will reach Volume Million USD in 2017 and CAGR xx% 201...

$ 2,980.00

Read More

Global Oncology Biosimilars Market Research Report Forecast 2017 to 2021

07 Jun 2017  |  Published by:  S&P Consulting
The Global Oncology Biosimilars Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Oncology Biosimilars industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). T...

$ 2,800.00

Read More

The Future of Biosimilars in Europe: Mapping critical uncertainties and the impact of future events

01 Jun 2017  |  Published by:  FirstWord
Education is top priority as biosimilar mAbs enter the marketWith the recent approval of Celltrion’s Truxima, all eyes are on biosimilar oncology monoclonal antibodies (mAbs). Experts say they’re the next frontier in the European biosimilars market, but warn that they may not achieve widespread upta...

$ 2,245.00

Read More

Global Biologics and Biosimilars Market Analysis 2011-2017 and Forecast 2018-2023

01 Jun 2017  |  Published by:  99Strategy
SnapshotA biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or ...

$ 2,980.00

Read More

EMEA (Europe, Middle East and Africa) Biologics and Biosimilars Market Report 2017

10 May 2017  |  Published by:  QYResearch
In this report, the EMEA Biologics and Biosimilars market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), ...

$ 4,000.00

Read More

Biosimilars Market in India 2017

01 Apr 2017  |  Published by:  Netscribes (India) Pvt. Ltd
Netscribes’ latest market research report titled Biosimilars Market in India 2017, describes the current and forecasted dynamics of the biosimilars market in India. The increasing incidence of diseases such as CVD and CHD, cancer and diabetes has led to an increase in the demand for these products a...

$ 1,995.00

Read More
Total 40 records.